Kiniciti’s Investment in Ncardia

AKD assisted Ncardia on the deal while Sidley Austin represented Kiniciti.

Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, secured more than US$60 million in capital through a strategic partnership with Kiniciti, a US-based investment platform focused on strengthening the cell and gene therapy ecosystem worldwide.

Kiniciti is backed by Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm investing in healthcare and technology, and Biospring Partners. The transaction gives Kiniciti a controlling stake in Ncardia to support growth and enhance capabilities spanning discovery to clinical programs to commercial production.

Ncardia is a human iPSC technology company developing stem cell-based solutions for drug discovery and cell therapy that operates worldwide with facilities, offices, and staff throughout Europe and North America.

Kiniciti, a platform company of leading private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners, invests in and partners with companies that have the potential to transform and strengthen the cell and gene therapy ecosystem.

AKD’s team consisted of Timothy Speelman (Picture) and Nathalie Locht.

The Sidley team was led by Private Equity partner Wim De Vlieger, supported by senior associate Lauren Bretton, associates Pieter Lavens, Zoe Woodhouse, and Lucy Carr. Additional support was provided by partners Oliver Currall, Jason Menzies, William RM Long, Susan Fanning, Sven De Knop, Maarten Meulenbelt, counsel Helen Middleton and Tom Bainbridge, senior associates Francesca Blythe, Peter McCorkell, Josefine Sommer, and Jörg Fischer, and associates Alex Down, Nicole Bieber, Pranith Mehta, Amadeus Moeser, Lauren Cuyvers, Justine Fassion, Ines Willemyns, and Alessandra Moroni.

Involved fees earner: Nathalie Locht – AKD; Timothy Speelman – AKD; Tom Bainbridge – Sidley Austin LLP; Nicole Bieber – Sidley Austin LLP; Francesca Blythe – Sidley Austin LLP; Lauren Bretton – Sidley Austin LLP; Lucy Carr – Sidley Austin LLP; Oliver Currall – Sidley Austin LLP; Lauren Cuyvers – Sidley Austin LLP; Sven De Knop – Sidley Austin LLP; Wim De Vlieger – Sidley Austin LLP; Alex Down – Sidley Austin LLP; Susan Fanning – Sidley Austin LLP; Justine Fassion – Sidley Austin LLP; Jörg Fischer – Sidley Austin LLP; Pieter Lavens – Sidley Austin LLP; William Long – Sidley Austin LLP; Peter McCorkell – Sidley Austin LLP; Pranith Mehta – Sidley Austin LLP; Jason Menzies – Sidley Austin LLP; Maarten Meulenbelt – Sidley Austin LLP; Helen Middleton – Sidley Austin LLP; Amadeus Moeser – Sidley Austin LLP; Alessandra Moroni – Sidley Austin LLP; Josefine Sommer – Sidley Austin LLP; Ines Willemyns – Sidley Austin LLP; Zoe Woodhouse – Sidley Austin LLP;

Law Firms: AKD; Sidley Austin LLP;

Clients: Kiniciti; Ncardia;

Naoual Sadouqi

Author: Naoual Sadouqi